Compare · IRTC vs NDRA

IRTC vs NDRA

Side-by-side comparison of iRhythm Holdings Inc. (IRTC) and ENDRA Life Sciences Inc. (NDRA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. IRTC focuses on Medical/Dental Instruments, while NDRA focuses on Biotechnology: Electromedical & Electrotherapeutic Apparatus.
  • IRTC is the larger of the two at $3.05B, about 461.1x NDRA ($6.6M).
  • IRTC has been more active in the news (10 items in the past 4 weeks vs 3 for NDRA).
  • IRTC has more recent analyst coverage (25 ratings vs 0 for NDRA).
MetricIRTCNDRA
Company
iRhythm Holdings Inc.
ENDRA Life Sciences Inc.
Price
-
-
Market cap
$3.05B
$6.6M
1M return
-
-5.51%
1Y return
-
-28.88%
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2016
2017
News (4w)
10
3
Recent ratings
25
0
IRTC

iRhythm Holdings Inc.

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

NDRA

ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Latest IRTC

Latest NDRA